COVID-19
The Latest
-
Health Experts Question Validity of 'Long COVID' Term, Citing Unnecessary Fear
In a surprising development, government-backed medical researchers in Australia are calling for the term "long COVID" to be abandoned, arguing that it creates unnecessary fear and may hinder patient recovery. 
In a surprising development, government-backed medical researchers in Australia are calling for the term "long COVID" to be abandoned, arguing that it creates unnecessary fear and may hinder patient recovery. -
Experts Warn CDC's Streamlined Respiratory Virus Guidance Could Misrepresent COVID-19 Risks
However, this change has sparked concern among public health experts who worry that the CDC's attempt to treat COVID-19 like other common respiratory viruses, such as influenza and respiratory syncytial virus (RSV), could misrepresent the risks associated with the virus. 
However, this change has sparked concern among public health experts who worry that the CDC's attempt to treat COVID-19 like other common respiratory viruses, such as influenza and respiratory syncytial virus (RSV), could misrepresent the risks associated with the virus. -
White House Ends COVID-19 Testing Requirement for Close Contacts of Biden and Harris
The White House announced on Monday the lifting of the COVID-19 testing mandate for individuals in close proximity to President Joe Biden, Vice President Kamala Harris, and their spouses. 
The White House announced on Monday the lifting of the COVID-19 testing mandate for individuals in close proximity to President Joe Biden, Vice President Kamala Harris, and their spouses. -
New CDC Guidelines End 5-Day Isolation, Emphasize Symptom Improvement for COVID-19
The Centers for Disease Control and Prevention (CDC) announced the cessation of its five-day isolation rule for individuals diagnosed with COVID-19. The updated guidance, reflecting a strategic pivot in managing the pandemic, now advises that individuals may resume normal activities once they exhibit symptom improvement and remain fever-free for at least 24 hours without the aid of medication. 
The Centers for Disease Control and Prevention (CDC) announced the cessation of its five-day isolation rule for individuals diagnosed with COVID-19. The updated guidance, reflecting a strategic pivot in managing the pandemic, now advises that individuals may resume normal activities once they exhibit symptom improvement and remain fever-free for at least 24 hours without the aid of medication. -
COVID Vaccines Associated with Uncommon Heart, Brain and Blood Disorders, Research Shows
COVID-19 vaccines from Pfizer, Moderna, and AstraZeneca have been associated with rare but increased occurrences of certain heart, brain, and blood disorders. 
COVID-19 vaccines from Pfizer, Moderna, and AstraZeneca have been associated with rare but increased occurrences of certain heart, brain, and blood disorders. -
JN.1 Variant Surges as Dominant COVID-19 Strain in U.S. But Does Not lead to More Severe Disease
As the United States grapples with the pervasive spread of the JN.1 variant, the latest iteration of COVID-19, both the medical community and the public are bracing for its implications. 
As the United States grapples with the pervasive spread of the JN.1 variant, the latest iteration of COVID-19, both the medical community and the public are bracing for its implications. -
China CDC Assesses Low Public Health Risk from JN.1 Variant Amid Rising Respiratory Diseases
On December 28, the Chinese National Health Commission held a press conference regarding the prevention and treatment of respiratory diseases in winter. On December 28, the Chinese National Health Commission held a press conference regarding the prevention and treatment of respiratory diseases in winter. -
New COVID-19 Variant JN.1 Spreads Rapidly in the U.S. During Holiday Season
As the U.S. enters the Christmas season, a new COVID-19 variant, known as JN.1, is rapidly spreading across the country, potentially leading to an increase in infections this winter. Meanwhile, interest in vaccination among Americans appears to be waning. As the U.S. enters the Christmas season, a new COVID-19 variant, known as JN.1, is rapidly spreading across the country, potentially leading to an increase in infections this winter. Meanwhile, interest in vaccination among Americans appears to be waning. -
COVID-19 JN.1 Variant Emerges as Dominant Strain in Singapore, Rapidly Spreading in the U.S.
JN.1 has recently garnered attention, especially in Asia, where it has become the dominant strain in Singapore. The Singapore Ministry of Health reported that COVID-19 cases jumped from over 22,000 to 32,035 in the week ending December 2, with 60% of these cases being the JN.1 variant. JN.1 has recently garnered attention, especially in Asia, where it has become the dominant strain in Singapore. The Singapore Ministry of Health reported that COVID-19 cases jumped from over 22,000 to 32,035 in the week ending December 2, with 60% of these cases being the JN.1 variant. -
U.S. Allocates $600 Million for Free COVID-19 Test Kits: Here's What You Need to Know
The U.S. is reinstating some COVID-19 related measures. 
The U.S. is reinstating some COVID-19 related measures.
